Exosome-like Nanoparticles Extracted from Plant Cells for Diabetes Therapy
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26189155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Xin Xiao und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences and Technology, Tongji University, Shanghai 200092, China. Hauptthemen laut MEDLINE: Exosomes, Nanoparticles, Diabetes Mellitus, Hypoglycemic Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Pujiang Program of the Shanghai Magnolia Talent Plan.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetes mellitus (DM) is a complex metabolic disorder characterized by chronic hyperglycemia and associated complications such as cardiovascular disease, nephropathy, retinopathy, neuropathy, and chronic non-healing wounds. Current antidiabetic therapies offer only partial glycemic control and are limited by poor bioavailability, adverse effects, and an inability to prevent disease progression. Plant-derived exosome-like nanoparticles (PENPs) have emerged as a promising class of natural nanocarriers with excellent biocompatibility, low immunogenicity, and intrinsic multi-component bioactivity. However, few reviews have addressed recent progress in PENPs for DM therapy. To capture the recent developments in this area, this review provides a systematic synthesis of recent advances in PENPs for DM therapy, covering plant sources, extraction and purification methods, molecular compositions, and therapeutic mechanisms. Preclinical studies have demonstrated that PENPs can improve hyperglycemia, enhance insulin sensitivity, regulate hepatic lipid metabolism, and promote wound healing by modulating oxidative stress, inflammation, gut microbiota, glucose metabolism, and insulin signaling. Additionally, PENPs have been shown to promote angiogenesis via glycolytic reprogramming. Despite these promising findings, challenges including scalable isolation, standardized physicochemical characterization, and clinical translation remain. Future directions include engineering multifunctional PENPs, establishing Good Manufacturing Practice (GMP)-compliant production, and conducting clinical trials to facilitate their integration into precision therapeutics for diabetes management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences and Technology, Tongji University, Shanghai 200092, China.
- Department of Biochemistry, School of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg 3209, South Africa.
- Department of Biochemistry, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa.
ORCID-Profile: Nontokozo Zimbili Msomi, Md Shahidul Islam
Förderung
- Shanghai Pujiang Program of the Shanghai Magnolia Talent Plan
Zitieren
APA
Xiao, X., Guo, Y., Msomi, N. Z., Islam, M. S., & Chu, M. (2025). Exosome-like Nanoparticles Extracted from Plant Cells for Diabetes Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26189155
Vancouver
Xiao X, Guo Y, Msomi NZ, Islam MS, Chu M. Exosome-like Nanoparticles Extracted from Plant Cells for Diabetes Therapy. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26189155
BibTeX
@article{Xiao2025,
author = {Xiao, Xin and Guo, Yuliang and Msomi, Nontokozo Zimbili and Islam, Md Shahidul and Chu, Maoquan},
title = {Exosome-like Nanoparticles Extracted from Plant Cells for Diabetes Therapy},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26189155}
}
EUVIMED